Omega Healthcare Investors (NYSE:OHI) Share Price Breaks Above 200-Day Moving Average - Here's Why

Key Points

• Omega Healthcare Investors shares moved above their 200-day moving average, reaching $47.29 compared with the $46.55 average, and last traded near $46.98.
• Analyst sentiment is mixed: the stock has a consensus “Hold” rating and a $49.93 average price target, despite several recent upgrades and downgrades.
• Omega reported quarterly EPS of $1.19, well above the $0.51 consensus estimate, while revenue rose 16.2% year over year to $328.25 million; institutional investors own 65.25% of the stock.

Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) shares passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $46.55 and traded as high as $47.29. Omega Healthcare Investors shares last traded at $46.9810, with a volume of 2,033,730 shares.

Wall Street Analyst Weigh In

OHI has been the topic of several analyst reports. UBS Group dropped their target price on Omega Healthcare Investors from $54.00 to $52.00 and set a "buy" rating on the stock in a report on Tuesday, October 13th. Wall Street Zen raised Omega Healthcare Investors from a "hold" rating to a "buy" rating in a report on Saturday, October 17th. Barclays decreased their price target on Omega Healthcare Investors from $50.00 to $48.00 and set an "underweight" rating for the company in a report on Tuesday, October 13th. Citizens Jmp upgraded Omega Healthcare Investors from a "market perform" rating to a "market outperform" rating and set a $52.00 price objective on the stock in a research report on Thursday, October 22nd. Finally, Citigroup raised shares of Omega Healthcare Investors from a "buy" rating to an "outperform" rating in a research note on Thursday. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $49.93.

Omega Healthcare Investors Stock Performance

The company has a market capitalization of $14.24 billion, a PE ratio of 16.78, a price-to-earnings-growth ratio of 1.87 and a beta of 0.53. The company has a 50 day simple moving average of $46.17 and a 200 day simple moving average of $46.55.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 EPS for the quarter, topping the consensus estimate of $0.51 by $0.68. The firm had revenue of $328.25 million during the quarter, compared to analysts' expectations of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%. The firm's revenue for the quarter was up 16.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current year.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of hedge funds have recently modified their holdings of OHI. Oppenheimer & Co. Inc. lifted its position in Omega Healthcare Investors by 4.3% in the third quarter. Oppenheimer & Co. Inc. now owns 63,631 shares of the real estate investment trust's stock valued at $2,947,000 after buying an additional 2,607 shares during the last quarter. Rainey & Randall Wealth Advisors Inc. boosted its position in Omega Healthcare Investors by 0.5% in the 3rd quarter. Rainey & Randall Wealth Advisors Inc. now owns 216,429 shares of the real estate investment trust's stock valued at $10,023,000 after buying an additional 1,127 shares during the period. Apollon Wealth Management LLC boosted its holdings in Omega Healthcare Investors by 11.9% in the third quarter. Apollon Wealth Management LLC now owns 25,770 shares of the real estate investment trust's stock valued at $1,193,000 after purchasing an additional 2,747 shares during the period. Samalin Investment Counsel LLC boosted its stake in shares of Omega Healthcare Investors by 6.4% in the 3rd quarter. Samalin Investment Counsel LLC now owns 31,945 shares of the real estate investment trust's stock valued at $1,479,000 after buying an additional 1,908 shares during the period. Finally, Signaturefd LLC lifted its stake in Omega Healthcare Investors by 15.9% in the third quarter. Signaturefd LLC now owns 8,300 shares of the real estate investment trust's stock worth $384,000 after acquiring an additional 1,140 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.